EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Announces Investigation of Securities Claims Against Liquidia Corporation – LQDABusiness Wire • 12/31/20
Liquidia Receives Complete Response Letter from FDA for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial HypertensionGlobeNewsWire • 11/25/20
Liquidia to Present at the 2020 Jefferies Virtual London Healthcare ConferenceGlobeNewsWire • 11/12/20
Liquidia Technologies, Inc. (LQDA) CEO Neal Fowler on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/09/20
Liquidia Reports Third Quarter 2020 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/09/20
Liquidia Reschedules Special Meeting of Stockholders and Reaffirms Recommendation to Approve Proposed Acquisition of RareGen, LLCGlobeNewsWire • 11/02/20
UPDATE – Liquidia to Report Third Quarter 2020 Financial Results and Provide Corporate Update on November 6, 2020GlobeNewsWire • 10/31/20
Liquidia to Report Third Quarter 2020 Financial Results and Provide Corporate Update on November 6, 2020GlobeNewsWire • 10/30/20
Liquidia Technologies: The Odds Of Approval Are Unclear, But The Potential Upside Makes It A Good BetSeeking Alpha • 10/19/20
Liquidia Provides Update on U.S. Patent Trial and Appeal Board Decision on Inter Partes Review of Two United Therapeutics’ Tyvaso® PatentsGlobeNewsWire • 10/14/20
Liquidia Names Gerald M. O’Brien, MD, as Vice President, Pulmonary Clinical DevelopmentGlobeNewsWire • 10/05/20
Liquidia Announces Special Meeting Date to Approve Proposed Acquisition of RareGen, LLCGlobeNewsWire • 09/17/20
Liquidia Announces Notice of Allowance for U.S. Patent Application Covering Methods of Treating Pulmonary Hypertension with Dry Powder TreprostinilGlobeNewsWire • 08/28/20
Liquidia Technologies, Inc. (LQDA) CEO Neal Fowler on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/11/20
Liquidia to Present at the 2020 Wedbush PacGrow Healthcare Virtual ConferenceGlobeNewsWire • 08/05/20
Liquidia Releases Exploratory Endpoint Data from INSPIRE Study at the American Thoracic Society (ATS) Annual MeetingGlobeNewsWire • 08/05/20
Liquidia to Report Second Quarter 2020 Financial Results and Provide Corporate Update on August 10, 2020GlobeNewsWire • 08/03/20
Liquidia Responds to United Therapeutics Corporation Lawsuit Alleging Infringement of New Tyvaso PatentGlobeNewsWire • 07/24/20